Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00315302 · ClinicalTrials.gov registry record · Phase 3

Trial Comparing Atropine to Atropine Plus a Plano Lens for the Sound Eye for Amblyopia in Children 3 to <7 Years Old

A Phase 3 study, sponsored by Jaeb Center for Health Research.

Completed
Registry status
Phase 3
Development phase
240
Enrollment target

NCT00315302 is a Phase 3 study that has completed, run by Jaeb Center for Health Research. The registered enrollment target is 240 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00315302, a Phase 3 study, has completed, sponsored by Jaeb Center for Health Research.

COMPLETED
Registry status
Phase 3
Development phase
240 participants
Enrollment target

Study Summary

The purpose of the study is: * To compare the effectiveness and safety of weekend atropine augmented with a plano lens for the sound eye versus weekend atropine alone for moderate amblyopia (20/40 to 20/100) in children 3 to less than 7 years old. * To provide data on the response of severe amblyopia (20/125 to 20/400) to atropine treatment with and without a plano lens.

Interventions

  • DRUG Atropine
  • DEVICE Plano Lens

Trial Details

FieldValue
Enrollment Target 240 participants
Start Date 2005-02
Est. Completion 2008-01
Phase Phase 3

Sponsor

Jaeb Center for Health Research

119 total trials

What the Registry Record Tells You About NCT00315302

The ClinicalTrials.gov registry entry for NCT00315302 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Jaeb Center for Health Research, which has 119 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Atropine is the first listed.

NCT00315302 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00315302 about?

NCT00315302 is a clinical study titled "Trial Comparing Atropine to Atropine Plus a Plano Lens for the Sound Eye for Amblyopia in Children 3 to <7 Years Old". The purpose of the study is: * To compare the effectiveness and safety of weekend atropine augmented with a plano lens for the sound eye versus weekend atropine alone for moderate amblyopia (20/40 to 20/100) in children 3 to less than 7 years old. * To provide data on the response of severe amblyop...

What is the current status of trial NCT00315302?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 240 participants. The study started on 2005-02. Estimated completion is 2008-01.

What interventions are being tested in trial NCT00315302?

The interventions under investigation include: Atropine (DRUG), Plano Lens (DEVICE).

Who is sponsoring clinical trial NCT00315302?

This trial is sponsored by Jaeb Center for Health Research, which has 119 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.